+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kadian"

Morphine Drugs Market Report 2025 - Product Thumbnail Image

Morphine Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Kadian market is a segment of the analgesics market, which is composed of drugs used to relieve pain. Kadian is a brand of extended-release morphine sulfate, an opioid analgesic used to treat moderate to severe pain. It is available in capsule form and is taken orally. Kadian is typically prescribed for long-term pain management, as it provides a steady, consistent level of pain relief over a longer period of time. It is also used to treat chronic pain, such as cancer pain, and is sometimes used in combination with other medications. Kadian is manufactured by several pharmaceutical companies, including Purdue Pharma, Endo Pharmaceuticals, and Mallinckrodt Pharmaceuticals. Other companies that produce similar extended-release morphine sulfate products include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Actavis. Show Less Read more